Discovery of semi-and fully-synthetic carbohydrate vaccines against bacterial infections using a medicinal chemistry approach: focus review

PH Seeberger - Chemical Reviews, 2021 - ACS Publications
The glycocalyx, a thick layer of carbohydrates, surrounds the cell wall of most bacterial and
parasitic pathogens. Recognition of these unique glycans by the human immune system …

Synthetic carbohydrate-based vaccines: challenges and opportunities

R Mettu, CY Chen, CY Wu - Journal of Biomedical Science, 2020 - Springer
Glycoconjugate vaccines based on bacterial capsular polysaccharides (CPS) have been
extremely successful in preventing bacterial infections. The glycan antigens for the …

Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection

D Zhu, JA Sorg, X Sun - Frontiers in cellular and infection microbiology, 2018 - frontiersin.org
Clostridioides difficile is a Gram-positive, spore-forming, toxin-producing anaerobe, and an
important nosocomial pathogen. Due to the strictly anaerobic nature of the vegetative form …

Development in the concept of bacterial polysaccharide repeating unit-based antibacterial conjugate vaccines

R Rohokale, Z Guo - ACS infectious diseases, 2023 - ACS Publications
The surface of cells is coated with a dense layer of glycans, known as the cell glycocalyx.
The complex glycans in the glycocalyx are involved in various biological events, such as …

Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen

MM Awad, PA Johanesen, GP Carter, E Rose… - Gut …, 2014 - Taylor & Francis
The worldwide emergence of epidemic strains of Clostridium difficile linked to increased
disease severity and mortality has resulted in greater research efforts toward determining …

Chemical biology approaches to designing defined carbohydrate vaccines

C Anish, B Schumann, CL Pereira, PH Seeberger - Chemistry & biology, 2014 - cell.com
Carbohydrate antigens have shown promise as important targets for developing effective
vaccines and pathogen detection strategies. Modifying purified microbial glycans through …

Clostridium difficile infection in the twenty-first century

C Ghose - Emerging microbes & infections, 2013 - Taylor & Francis
Clostridium difficile is a spore-forming gram-positive bacillus, and the leading cause of
antibiotic-associated nosocomial diarrhea and colitis in the industrialized world. With the …

A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum …

E Sheldon, N Kitchin, Y Peng, J Eiden, W Gruber… - Vaccine, 2016 - Elsevier
Introduction Clostridium difficile is a significant cause of morbidity and mortality in hospitals,
nursing homes, and long-term care facilities. The bacteria can produce 3 toxins, of which the …

Vaccines against Clostridium difficile

R Leuzzi, R Adamo, M Scarselli - Human vaccines & …, 2014 - Taylor & Francis
Clostridium difficile infection (CDI) is recognized as a major cause of nosocomial diseases
ranging from antibiotic related diarrhea to fulminant colitis. Emergence during the last 2 …

A vaccine and diagnostic target for Clostridium bolteae, an autism-associated bacterium

B Pequegnat, M Sagermann, M Valliani, M Toh… - Vaccine, 2013 - Elsevier
Constipation and diarrhea are common in autistic patients. Treatment with antibiotics against
bacteria appears to partially alleviate autistic-related symptoms. Clostridium bolteae is a …